Anaptysbio

Developer of immunology therapeutics for cancer and inflammatory diseases

placeSan Diego, California, United States calendar_todayFounded 2005 groups101 employees language anaptysbio.com

Registered entities

Social engagement

Social engagement: 12K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

15 investors on record; lead investors include BVF Partners, BioMedPartners, Frazier Healthcare Partners, LONGWOOD INVESTMENT ADVISORS; 4 have since exited.

Investor typeCountShare
Venture capital747%
Private equity640%
Other / undisclosed213%

Recent activity

12 May 2026
Leadership hire
Board of Directors
11 May 2026
Leadership hire
Chief Financial Officer
15 Apr 2026
Product launch
First Tracks Biotherapeutics
Coming soon